UniProt ID | IF2A_HUMAN | |
---|---|---|
UniProt AC | P05198 | |
Protein Name | Eukaryotic translation initiation factor 2 subunit 1 | |
Gene Name | EIF2S1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 315 | |
Subcellular Localization | Cytoplasm, Stress granule . Colocalizes with NANOS3 in the stress granules. | |
Protein Description | Functions in the early steps of protein synthesis by forming a ternary complex with GTP and initiator tRNA. This complex binds to a 40S ribosomal subunit, followed by mRNA binding to form a 43S pre-initiation complex. Junction of the 60S ribosomal subunit to form the 80S initiation complex is preceded by hydrolysis of the GTP bound to eIF-2 and release of an eIF-2-GDP binary complex. In order for eIF-2 to recycle and catalyze another round of initiation, the GDP bound to eIF-2 must exchange with GTP by way of a reaction catalyzed by eIF-2B.. | |
Protein Sequence | MPGLSCRFYQHKFPEVEDVVMVNVRSIAEMGAYVSLLEYNNIEGMILLSELSRRRIRSINKLIRIGRNECVVVIRVDKEKGYIDLSKRRVSPEEAIKCEDKFTKSKTVYSILRHVAEVLEYTKDEQLESLFQRTAWVFDDKYKRPGYGAYDAFKHAVSDPSILDSLDLNEDEREVLINNINRRLTPQAVKIRADIEVACYGYEGIDAVKEALRAGLNCSTENMPIKINLIAPPRYVMTTTTLERTEGLSVLSQAMAVIKEKIEEKRGVFNVQMEPKVVTDTDETELARQMERLERENAEVDGDDDAEEMEAKAED | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Phosphorylation | PGLSCRFYQHKFPEV CCCCCEEEECCCCCC | 7.14 | 29496907 | |
12 | Acetylation | SCRFYQHKFPEVEDV CCEEEECCCCCCEEE | 47.27 | 26051181 | |
12 | Ubiquitination | SCRFYQHKFPEVEDV CCEEEECCCCCCEEE | 47.27 | - | |
26 | Phosphorylation | VVMVNVRSIAEMGAY EEEEEHHHHHHHCCE | 23.13 | 26552605 | |
33 | Phosphorylation | SIAEMGAYVSLLEYN HHHHHCCEEEEEHCC | 5.71 | 27251275 | |
35 | Phosphorylation | AEMGAYVSLLEYNNI HHHCCEEEEEHCCCC | 17.98 | 27251275 | |
39 | Phosphorylation | AYVSLLEYNNIEGMI CEEEEEHCCCCCHHH | 17.30 | 27251275 | |
49 | Phosphorylation | IEGMILLSELSRRRI CCHHHHHHHHHHHHH | 32.80 | 21082442 | |
52 | Phosphorylation | MILLSELSRRRIRSI HHHHHHHHHHHHHHH | 21.49 | 14676213 | |
58 | Phosphorylation | LSRRRIRSINKLIRI HHHHHHHHHHHHHHC | 28.30 | 20068231 | |
61 | Ubiquitination | RRIRSINKLIRIGRN HHHHHHHHHHHCCCC | 43.55 | 21890473 | |
61 | Malonylation | RRIRSINKLIRIGRN HHHHHHHHHHHCCCC | 43.55 | 26320211 | |
61 | Acetylation | RRIRSINKLIRIGRN HHHHHHHHHHHCCCC | 43.55 | 25953088 | |
78 | Ubiquitination | VVVIRVDKEKGYIDL EEEEEEECCCCEEEC | 59.47 | - | |
80 | Ubiquitination | VIRVDKEKGYIDLSK EEEEECCCCEEECCC | 63.86 | - | |
80 | 2-Hydroxyisobutyrylation | VIRVDKEKGYIDLSK EEEEECCCCEEECCC | 63.86 | - | |
82 | Phosphorylation | RVDKEKGYIDLSKRR EEECCCCEEECCCCC | 11.43 | 28152594 | |
86 | Phosphorylation | EKGYIDLSKRRVSPE CCCEEECCCCCCCHH | 21.99 | 24719451 | |
87 | 2-Hydroxyisobutyrylation | KGYIDLSKRRVSPEE CCEEECCCCCCCHHH | 52.07 | - | |
87 | Acetylation | KGYIDLSKRRVSPEE CCEEECCCCCCCHHH | 52.07 | 25953088 | |
87 | Ubiquitination | KGYIDLSKRRVSPEE CCEEECCCCCCCHHH | 52.07 | 21906983 | |
91 | Phosphorylation | DLSKRRVSPEEAIKC ECCCCCCCHHHHHCC | 25.45 | 23927012 | |
97 | Ubiquitination | VSPEEAIKCEDKFTK CCHHHHHCCCHHCCC | 38.32 | - | |
97 | Acetylation | VSPEEAIKCEDKFTK CCHHHHHCCCHHCCC | 38.32 | 26051181 | |
101 | Acetylation | EAIKCEDKFTKSKTV HHHCCCHHCCCHHHH | 32.41 | 25825284 | |
101 | Ubiquitination | EAIKCEDKFTKSKTV HHHCCCHHCCCHHHH | 32.41 | - | |
103 | Phosphorylation | IKCEDKFTKSKTVYS HCCCHHCCCHHHHHH | 39.90 | 23312004 | |
104 | Ubiquitination | KCEDKFTKSKTVYSI CCCHHCCCHHHHHHH | 53.76 | - | |
106 | Malonylation | EDKFTKSKTVYSILR CHHCCCHHHHHHHHH | 43.49 | 26320211 | |
106 | Ubiquitination | EDKFTKSKTVYSILR CHHCCCHHHHHHHHH | 43.49 | 21890473 | |
107 | Phosphorylation | DKFTKSKTVYSILRH HHCCCHHHHHHHHHH | 31.59 | 23186163 | |
109 | Phosphorylation | FTKSKTVYSILRHVA CCCHHHHHHHHHHHH | 8.67 | 28152594 | |
110 | Phosphorylation | TKSKTVYSILRHVAE CCHHHHHHHHHHHHH | 15.71 | 21815630 | |
123 | Ubiquitination | AEVLEYTKDEQLESL HHHHHHCCHHHHHHH | 59.37 | 21906983 | |
123 | 2-Hydroxyisobutyrylation | AEVLEYTKDEQLESL HHHHHHCCHHHHHHH | 59.37 | - | |
123 | Acetylation | AEVLEYTKDEQLESL HHHHHHCCHHHHHHH | 59.37 | 26051181 | |
133 | Methylation | QLESLFQRTAWVFDD HHHHHHHHHHHHCCC | 21.05 | - | |
141 | 2-Hydroxyisobutyrylation | TAWVFDDKYKRPGYG HHHHCCCCCCCCCCC | 55.29 | - | |
141 | Acetylation | TAWVFDDKYKRPGYG HHHHCCCCCCCCCCC | 55.29 | 19608861 | |
141 | Ubiquitination | TAWVFDDKYKRPGYG HHHHCCCCCCCCCCC | 55.29 | 21890473 | |
143 | Malonylation | WVFDDKYKRPGYGAY HHCCCCCCCCCCCHH | 58.83 | 32601280 | |
143 | Acetylation | WVFDDKYKRPGYGAY HHCCCCCCCCCCCHH | 58.83 | 26051181 | |
143 | Ubiquitination | WVFDDKYKRPGYGAY HHCCCCCCCCCCCHH | 58.83 | 21890473 | |
147 | Phosphorylation | DKYKRPGYGAYDAFK CCCCCCCCCHHHHHH | 10.98 | 28152594 | |
150 | Phosphorylation | KRPGYGAYDAFKHAV CCCCCCHHHHHHHHC | 11.93 | 28152594 | |
154 | Ubiquitination | YGAYDAFKHAVSDPS CCHHHHHHHHCCCHH | 32.16 | 21906983 | |
154 | Methylation | YGAYDAFKHAVSDPS CCHHHHHHHHCCCHH | 32.16 | - | |
158 | Phosphorylation | DAFKHAVSDPSILDS HHHHHHCCCHHHHHC | 44.58 | 30266825 | |
161 | Phosphorylation | KHAVSDPSILDSLDL HHHCCCHHHHHCCCC | 40.55 | 23663014 | |
165 | Phosphorylation | SDPSILDSLDLNEDE CCHHHHHCCCCCHHH | 21.97 | 29214152 | |
185 | Phosphorylation | NNINRRLTPQAVKIR HHHHCCCCCCCEEEC | 16.14 | 30266825 | |
190 | Ubiquitination | RLTPQAVKIRADIEV CCCCCCEEECCCEEE | 29.50 | 1906983 | |
190 | 2-Hydroxyisobutyrylation | RLTPQAVKIRADIEV CCCCCCEEECCCEEE | 29.50 | - | |
199 | Glutathionylation | RADIEVACYGYEGID CCCEEEEECCCCCHH | 3.06 | 22555962 | |
200 | Phosphorylation | ADIEVACYGYEGIDA CCEEEEECCCCCHHH | 17.01 | 22817900 | |
202 | Phosphorylation | IEVACYGYEGIDAVK EEEEECCCCCHHHHH | 5.63 | 27642862 | |
209 | Ubiquitination | YEGIDAVKEALRAGL CCCHHHHHHHHHCCC | 38.70 | - | |
219 | O-linked_Glycosylation | LRAGLNCSTENMPIK HHCCCCCCCCCCCEE | 37.37 | 28657654 | |
219 | Phosphorylation | LRAGLNCSTENMPIK HHCCCCCCCCCCCEE | 37.37 | 21712546 | |
223 | Sulfoxidation | LNCSTENMPIKINLI CCCCCCCCCEEEEEE | 2.71 | 21406390 | |
226 | Ubiquitination | STENMPIKINLIAPP CCCCCCEEEEEECCC | 21.48 | - | |
235 | Phosphorylation | NLIAPPRYVMTTTTL EEECCCCEEEEECCE | 10.59 | 29496907 | |
237 | Sulfoxidation | IAPPRYVMTTTTLER ECCCCEEEEECCEEC | 1.72 | 30846556 | |
239 | O-linked_Glycosylation | PPRYVMTTTTLERTE CCCEEEEECCEECCC | 10.33 | 28657654 | |
240 | O-linked_Glycosylation | PRYVMTTTTLERTEG CCEEEEECCEECCCC | 21.88 | 28657654 | |
241 | O-linked_Glycosylation | RYVMTTTTLERTEGL CEEEEECCEECCCCH | 25.24 | 28657654 | |
245 | Phosphorylation | TTTTLERTEGLSVLS EECCEECCCCHHHHH | 25.65 | 21406692 | |
249 | Phosphorylation | LERTEGLSVLSQAMA EECCCCHHHHHHHHH | 31.69 | 21406692 | |
252 | Phosphorylation | TEGLSVLSQAMAVIK CCCHHHHHHHHHHHH | 17.46 | 21406692 | |
259 | Ubiquitination | SQAMAVIKEKIEEKR HHHHHHHHHHHHHHC | 46.48 | 21906983 | |
261 | Ubiquitination | AMAVIKEKIEEKRGV HHHHHHHHHHHHCCC | 50.87 | - | |
265 | Ubiquitination | IKEKIEEKRGVFNVQ HHHHHHHHCCCCEEE | 41.48 | - | |
266 | Methylation | KEKIEEKRGVFNVQM HHHHHHHCCCCEEEE | 50.19 | - | |
273 | Sulfoxidation | RGVFNVQMEPKVVTD CCCCEEEECCEEECC | 9.19 | 21406390 | |
276 | Ubiquitination | FNVQMEPKVVTDTDE CEEEECCEEECCCCH | 35.71 | 21906983 | |
276 | Acetylation | FNVQMEPKVVTDTDE CEEEECCEEECCCCH | 35.71 | 26051181 | |
279 | Phosphorylation | QMEPKVVTDTDETEL EECCEEECCCCHHHH | 35.85 | 30266825 | |
281 | Phosphorylation | EPKVVTDTDETELAR CCEEECCCCHHHHHH | 26.77 | 30266825 | |
284 | Phosphorylation | VVTDTDETELARQME EECCCCHHHHHHHHH | 38.82 | 30266825 | |
309 | Sulfoxidation | GDDDAEEMEAKAED- CCCCHHHHHHHHCC- | 4.58 | 28465586 | |
312 | Ubiquitination | DAEEMEAKAED---- CHHHHHHHHCC---- | 38.72 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
49 | S | Phosphorylation | Kinase | EIF2AK1 | Q9BQI3 | GPS |
49 | S | Phosphorylation | Kinase | EIF2AK2 | P19525 | GPS |
49 | S | Phosphorylation | Kinase | EIF2AK3 | Q9NZJ5 | GPS |
52 | S | Phosphorylation | Kinase | EIF2AK1 | Q9BQI3 | GPS |
52 | S | Phosphorylation | Kinase | EIF2AK2 | P19525 | GPS |
52 | S | Phosphorylation | Kinase | EIF2AK3 | Q9NZJ5 | GPS |
52 | S | Phosphorylation | Kinase | PERK | Q9Z2B5 | PSP |
52 | S | Phosphorylation | Kinase | RPS6KA3 | P51812 | GPS |
52 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
52 | S | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IF2A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
EI2BA_HUMAN | EIF2B1 | physical | 9446619 | |
E2AK2_HUMAN | EIF2AK2 | physical | 19364808 | |
IF2B_HUMAN | EIF2S2 | physical | 22939629 | |
IF2G_HUMAN | EIF2S3 | physical | 22939629 | |
POP1_HUMAN | POP1 | physical | 22939629 | |
TMED9_HUMAN | TMED9 | physical | 22939629 | |
NCOA5_HUMAN | NCOA5 | physical | 22939629 | |
STRN_HUMAN | STRN | physical | 22939629 | |
YBOX1_HUMAN | YBX1 | physical | 22939629 | |
AIMP1_HUMAN | AIMP1 | physical | 22863883 | |
SYDC_HUMAN | DARS | physical | 22863883 | |
MCA3_HUMAN | EEF1E1 | physical | 22863883 | |
IF2G_HUMAN | EIF2S3 | physical | 22863883 | |
MAP4_HUMAN | MAP4 | physical | 22863883 | |
SYMC_HUMAN | MARS | physical | 22863883 | |
SYQ_HUMAN | QARS | physical | 22863883 | |
RL13_HUMAN | RPL13 | physical | 22863883 | |
RL15_HUMAN | RPL15 | physical | 22863883 | |
RL27A_HUMAN | RPL27A | physical | 22863883 | |
RL7A_HUMAN | RPL7A | physical | 22863883 | |
RLA0_HUMAN | RPLP0 | physical | 22863883 | |
RS27L_HUMAN | RPS27L | physical | 22863883 | |
IF2G_HUMAN | EIF2S3 | physical | 26344197 | |
RPB7_HUMAN | POLR2G | physical | 26344197 | |
RPN1_HUMAN | RPN1 | physical | 26344197 | |
TOE1_HUMAN | TOE1 | physical | 26344197 | |
CDC37_HUMAN | CDC37 | physical | 12930845 | |
HS90A_HUMAN | HSP90AA1 | physical | 12930845 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-141, AND MASS SPECTROMETRY. |